International Journal of Cardiology
Volume 142, Issue 1 , Pages 44-49 , 25 June 2010

Recurrence of cerebrovascular events in young adults with a secundum atrial septal defect

  • Sjoukje I. Lok

      Affiliations

    • University of Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Bjorn Winkens

      Affiliations

    • Department of Methodology and Statistics, University of Maastricht, P.O. Box 616, 6200 MD Maastricht, The Netherlands
    • ,
  • Konstantinos Dimopoulos

      Affiliations

    • Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom
    • ,
  • Susan M. Fernandes

      Affiliations

    • Boston Adult Congenital Heart Service, Department of Cardiology, Children's Hospital and Brigham and Women's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA
    • ,
  • Michael A. Gatzoulis

      Affiliations

    • Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom
    • ,
  • Michael J. Landzberg

      Affiliations

    • Boston Adult Congenital Heart Service, Department of Cardiology, Children's Hospital and Brigham and Women's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA
    • ,
  • Barbara J.M. Mulder

      Affiliations

    • Department of Cardiology, Academic Medical Centre, Amsterdam, The Netherlands
    • Department of Cardiology, University Medical Center, Utrecht, The Netherlands
    • Interuniversity Cardiology Institute Netherlands (ICIN/KNAW), Catharijnesingel 52, 3511 GC, Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author. Academic Medical Centre, Department of Cardiology, B2-240, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Tel.: +31 20 566 2193; fax: +31 20 697 1385.

Received 19 August 2008 ,Accepted 13 December 2008.

References 

  1. Nencini P, Inzitari D, Baruffi MC, et al. Incidence of stroke in young adults in Florence, Italy. Stroke. 1988;19:977–981
  2. Jacobs BS, Boden-Albala B, Lin IF, Sacco RL. Stroke in the young in the northern Manhattan stroke study. Stroke. 2002;33:2789–2793
  3. Marini C, Totaro R, De Santis F, Ciancarelli I, Baldassarre M, Carolei A. Stroke in young adults in the community-based L'Aquila registry: incidence and prognosis. Stroke. 2001;32:52–56
  4. Leys D, Bandu L, Henon H, et al. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology. 2002;59:26–33
  5. Varona JF, Bermejo F, Guerra JM, Molina JA. Long-term prognosis of ischemic stroke in young adults. J Neurol. 2004;251:1507–1514
  6. Nedeltchev K, der Maur TA, Georgiadis D, et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry. 2005;76:191–195
  7. Slottow TLP, Steinberg DH, Waksman R. Overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on patent foramen ovale closure devices. Circulation. 2007;116:677–682
  8. van der Velde ET, Vriend JW, Mannens MM, Uiterwaal CS, Brand R, Mulder BJ. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol. 2005;20:549–557
  9. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007;49:797–802
  10. Rice MJ, McDonald RW, Reller MD. Fetal atrial septal aneurysm: a cause of fetal atrial arrhythmias. J Am Coll Cardiol. 1988;12:1292–1297
  11. Berthet K, Lavergne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke. 2000;31:398–403
  12. Mattioli AV, Aquilina M, Oldani A, Longhini C, Mattioli G. Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carotid arteries. A multicentre study. Eur Heart J. 2001;22:261–268
  13. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740–1746
  14. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625–2631
  15. Engelfriet PM, Tijssen JGP, Kaemmerer H, et al. Adherence to guidelines in the clinical care for adults with congenital heart disease. The Euro Heart Survey on adult congenital heart disease. Eur Heart J. 2006;27:737–745
  16. Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medically treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol. 2004;44:750–758
  17. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systemic review. Ann Intern Med. 2003;139:753–760
  18. Bungard TJ, Ackman ML, Geotham HO, Tsuyuki RT. Adequacy of anticoagulation in patients with atrial fibrillation coming to a hospital. Pharmacotherapy. 2000;20:1060–1065
  19. Malik AK, Taylor AJ. Can warfarin randomized trials be reproduced in “real life”? Adherence to warfarin guidelines for intensity of anticoagulation in a university-based warfarin clinic. South Med J. 2000;93:58–61
  20. Albers GW, Amareno P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:483–512
  21. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113:409–449
  22. Slavin L, Tobis J, Rangarajan K, Dao C, Krivokapich J, Liebeskind D. Five-year experience with percutaneous closure of PFO. Am J Cardiol. 2007;99:1316–1320
  23. Cooke JC, Gelman JS, Menahem S, Harper RW. Thrombus on an ASD closure device: a call for caution. Heart Lung Circ. 2000;9:30–31
  24. Raghu A, Kawalsky D, Feldman M. Embolic stroke due to a left atrial thrombus two years after placement of an atrial septal defect closure device. Am J Cardiol. 2006;98:1294–1296
  25. Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure in 1000 consecutive patients. J Am Coll Cardiol. 2004;43:302–309
  26. Anzai H, Child J, Natterson B, et al. Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol. 2004;93:426–431
  27. Divchev D, Schaefer A, Fuchs M, Breymann T, Drexler H, Meyer GP. Thrombus formation on an atrial septal defect closure device: a case report and review of the literature. Eur J Echocardiog. 2007;8:53–56
  28. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

☆ The authors have no conflicts of interest to disclose, there is no grant support.

PII: S0167-5273(08)01477-0

doi: 10.1016/j.ijcard.2008.12.085

International Journal of Cardiology
Volume 142, Issue 1 , Pages 44-49 , 25 June 2010

Article Tools

* Image Usage & Resolution